Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonin in Alzheimer-type dementia and other dementing illnesses.

Literature DB >> 1701291

Serotonin in Alzheimer-type dementia and other dementing illnesses.

A J Cross¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1990 PMID： 1701291 DOI： 10.1111/j.1749-6632.1990.tb16897.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Clinical pharmacology and therapeutics.

Authors: R C Horton; M J Kendall
Journal: Postgrad Med J Date: 1991-12 Impact factor: 2.401

2. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.

Authors: Katsuyoshi Mizukami; Masanori Ishikawa; Hiroyasu Akatsu; Eric E Abrahamson; Milos D Ikonomovic; Takashi Asada
Journal: Neuropathology Date: 2011-01-27 Impact factor: 1.906

Review 3. Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.

Authors: Irene Bolea; Alejandro Gella; Mercedes Unzeta
Journal: J Neural Transm (Vienna) Date: 2012-12-13 Impact factor: 3.575

Review 4. Neuronal Network Oscillations in Neurodegenerative Diseases.

Authors: Volker Nimmrich; Andreas Draguhn; Nikolai Axmacher
Journal: Neuromolecular Med Date: 2015-04-29 Impact factor: 3.843

5. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease.

Authors: Marco Calabrò; Laura Mandelli; Concetta Crisafulli; Stefano Porcelli; Diego Albani; Antonis Politis; George N Papadimitriou; Marco Di Nicola; Luigi Janiri; Roberto Colombo; Giovanni Martinotti; Antonello Bellomo; Eduard Vieta; Stefano Bonassi; Alessandra Frustaci; Giuseppe Ducci; Stefano Landi; Stefania Boccia; Alessandro Serretti
Journal: Mol Biol Rep Date: 2019-10-08 Impact factor: 2.316

10. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.

Authors: T Yoshitake; S Yoshitake; J Kehr
Journal: Br J Pharmacol Date: 2010-01-25 Impact factor: 8.739

Serotonin in Alzheimer-type dementia and other dementing illnesses.

Review 1. Clinical pharmacology and therapeutics.

2. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.

Review 3. Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.

Review 4. Neuronal Network Oscillations in Neurodegenerative Diseases.

5. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease.

Review 6. Genetics of psychosis in Alzheimer's disease: a review.

Review 7. The application of positron-emitting molecular imaging tracers in Alzheimer's disease.

8. 6-Hydroxydopamine induced impairment of Pavlovian conditioning in the rabbit.

9. Genetics of Psychosis in Alzheimer Disease.

10. The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.